Alpine Woods Capital Investors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
N
Alpine Woods Capital Investors's IBB Position: Q2 2018 in Review
Alpine Woods Capital Investors sold out of iShares Biotechnology ETF (IBB) in Q2 2018, closing a stake of 133,200 shares — an estimated $14.2M sold.
Alpine Woods Capital Investors first reported a position in IBB in Q4 2017 and held it in 2 quarters. The position peaked at $14.2M in Q4 2017. 609 funds tracked by Wall St. Rank hold IBB as of Q2 2018.
- Alpine Woods Capital Investors reported no remaining iShares Biotechnology ETF position as of Q2 2018 after selling out during the quarter.
- Alpine Woods Capital Investors sold 133,200 iShares Biotechnology ETF shares in Q2 2018, an estimated $14.2M.
- Alpine Woods Capital Investors first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 2 quarters.
- Alpine Woods Capital Investors's iShares Biotechnology ETF position peaked at $14.2M in Q4 2017.
- 609 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2018.
Based on Alpine Woods Capital Investors's 13F filing for Q2 2018, filed 9 Aug 2018.